抗药物治疗的低血症:叙述性综述
Kristin Nicole Bembenick1, Jibin Mathew2, Michael Heisler2
1School of Medicine, Louisiana State University Health Sciences Center, Shreveport, USA.
Cureus
|May 6, 2024
概括
低血症是一种危险的电解质失衡,是抗发作药物 (ASM) 的重要副作用. 密切监测迹象和症状对于ASM患者至关重要,如卡巴马泽和酸.
科学领域:
- 神经学 神经学
- 临床药理学 临床药理学
- 内部医学 内部医学
背景情况:
- 低血是抗发作药物 (ASM) 的常见副作用.
- 它是由电解质失衡引起的,并且与年龄,性别,剂量和药物组合等危险因素有关.
- 某些ASM,包括碳胺 (CBZ),氧胺 (OXC) 和酸,具有更高的风险.
研究的目的:
- 审查由ASM诱导的低血症的机制,危险因素,临床表现和管理.
- 强调识别和管理这种可能致命的副作用的重要性.
主要方法:
- 关于ASM及其与低血量相关性的文献综述.
- 风险因素,作用机制和临床表现的分析.
- 讨论治疗策略和快速纠正并发症.
主要成果:
- 低血症可以通过各种药物特定机制发生.
- 急性低血 (<48小时) 呈现出严重的症状,如妄想和发作,而慢性低血 (>48小时) 则导致昏迷和混乱.
- 低血与增加住院时间和死亡率有关.
结论:
- 医疗保健提供者必须对ASM诱导的低血症保持警.
- 迅速识别症状,根据严重程度和患者因素量身定制治疗,并意识到快速纠正风险是必不可少的.
- 有效的管理需要了解药物,患者概况和症状严重程度.
相关概念视频
Antiepileptic Drugs: Potassium Channel Activators
176
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
176
Mania and Antimanic Drugs: Overview
174
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
174
Antiepileptic Drugs: Sodium Channel Blockers
514
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
514
Antiepileptic Drugs: Glutamate Antagonists
321
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
321
Antiepileptic Drugs: GABAergic Pathway Potentiators
387
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
387
Antiepileptic Drugs: Calcium Channel Blockers
375
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
375


